PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-76.37%
Negative revenue growth while ECL.AX stands at 22.82%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-60.22%
Negative gross profit growth while ECL.AX is at 14.18%. Joel Greenblatt would examine cost competitiveness or demand decline.
-82.23%
Negative EBIT growth while ECL.AX is at 32.55%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-82.23%
Negative operating income growth while ECL.AX is at 32.55%. Joel Greenblatt would press for urgent turnaround measures.
-81.32%
Negative net income growth while ECL.AX stands at 46.33%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-80.00%
Negative EPS growth while ECL.AX is at 46.41%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-80.00%
Negative diluted EPS growth while ECL.AX is at 46.41%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
4.62%
Share count expansion well above ECL.AX's 0.02%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
12.14%
Diluted share change of 12.14% while ECL.AX is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
-54.43%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-32.83%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-50.22%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
112.77%
5Y revenue/share CAGR at 50-75% of ECL.AX's 153.94%. Martin Whitman would worry about a lagging mid-term growth trajectory.
49.41%
3Y revenue/share CAGR at 50-75% of ECL.AX's 95.23%. Martin Whitman would question if the firm lags behind competitor innovations.
4276.79%
Positive long-term OCF/share growth while ECL.AX is negative. John Neff would see a structural advantage in sustained cash generation.
457.75%
Positive OCF/share growth while ECL.AX is negative. John Neff might see a comparative advantage in operational cash viability.
259.99%
Positive 3Y OCF/share CAGR while ECL.AX is negative. John Neff might see a big short-term edge in operational efficiency.
121.31%
Positive 10Y CAGR while ECL.AX is negative. John Neff might see a substantial advantage in bottom-line trajectory.
2783.33%
5Y net income/share CAGR above 1.5x ECL.AX's 114.71%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
0.58%
Below 50% of ECL.AX's 88.65%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
609.64%
5Y equity/share CAGR above 1.5x ECL.AX's 27.74%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
87.12%
3Y equity/share CAGR above 1.5x ECL.AX's 17.34%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-76.11%
Firm’s AR is declining while ECL.AX shows 29.44%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
5.31%
Inventory growth well above ECL.AX's 0.14%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
1.87%
Asset growth at 50-75% of ECL.AX's 2.83%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
-0.88%
We have a declining book value while ECL.AX shows 4.80%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-13.08%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-35.81%
We cut SG&A while ECL.AX invests at 7.46%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.